Abcam (ABCM) Stock Forecast, Price & News

Abcam (NASDAQ:ABCM) Frequently Asked Questions

Is Abcam a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Abcam stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABCM, but not buy additional shares or sell existing shares.
View analyst ratings for Abcam or view top-rated stocks.

What price target have analysts set for ABCM?

4 Wall Street analysts have issued 1-year target prices for Abcam's shares. Their forecasts range from $20.00 to $1,700.00. On average, they anticipate Abcam's stock price to reach $1,073.33 in the next twelve months. This suggests a possible upside of 7,297.2% from the stock's current price.
View analysts' price targets for Abcam or view top-rated stocks among Wall Street analysts.

Who are Abcam's key executives?

Abcam's management team includes the following people:

• Mr. Alan Thomas Hirzel BS, M.B.A., M.S., MBA, MS, CEO & Exec. Director (Age 54, Pay $1.55M)
• Mr. Michael Shaun Baldock B.A., CFO & Director (Age 58, Pay $1.11M)
• Mr. Mark Dermody, Interim CIO
• James Staveley, VP of Investor Relations
• Marc Perkins, Gen. Counsel & Company Sec.
• Emma Sceats, Sr. VP of Sales, Service & Bus. Devel.
• Mr. Nick Skinner, Sr. VP of HR
• Mr. Mark Bushfield, Sr. VP of Research & Innovation
• Ms. Kirstie Speck BBusSc, Head of Consumer Insights
• Ms. Yvonne Chien, Sr. VP of Customer Experience

Who are some of Abcam's key competitors?

Some companies that are related to Abcam include Qiagen (QGEN), Qiagen (QGEN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Halozyme Therapeutics (HALO), Exelixis (EXEL), Ginkgo Bioworks (DNA), Novavax (NVAX), CRISPR Therapeutics (CRSP), Ablynx (ABLYF), Vir Biotechnology (VIR), Denali Therapeutics (DNLI), Iovance Biotherapeutics (IOVA), Beam Therapeutics (BEAM) and Bavarian Nordic A/S (BVNRY).
View all of ABCM's competitors.

When did Abcam IPO?

(ABCM) raised $149 million in an initial public offering (IPO) on Thursday, October 22nd 2020. The company issued 9,000,000 shares at $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair acted as the underwriters for the IPO.

What is Abcam's stock symbol?

Abcam trades on the NASDAQ under the ticker symbol "ABCM."

Who are Abcam's major shareholders?

Abcam's stock is owned by a number of institutional and retail investors. Top institutional investors include Wellington Management Group LLP (3.76%), Brown Advisory Inc. (1.27%), Champlain Investment Partners LLC (1.10%), BlackRock Inc. (0.64%), Rock Springs Capital Management LP (0.63%) and Bank of New York Mellon Corp (0.27%).

Which institutional investors are selling Abcam stock?

ABCM stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Natixis Advisors L.P., TD Asset Management Inc., and Citigroup Inc..

Which institutional investors are buying Abcam stock?

ABCM stock was bought by a variety of institutional investors in the last quarter, including Brown Advisory Inc., BlackRock Inc., Rock Springs Capital Management LP, Champlain Investment Partners LLC, Bank of New York Mellon Corp, First Manhattan Co., Royal Bank of Canada, and Truist Financial Corp.

How do I buy shares of Abcam?

Shares of ABCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Abcam's stock price today?

One share of ABCM stock can currently be purchased for approximately $14.51.

How much money does Abcam make?

Abcam has a market capitalization of $3.32 billion and generates $401.06 million in revenue each year.

How many employees does Abcam have?

Abcam employs 1,682 workers across the globe.

What is Abcam's official website?

The official website for Abcam is www.abcam.com.

How can I contact Abcam?

The company can be reached via phone at 44-0-12-2369-6000 or via email at [email protected].